校正:最近的发展口服药物输送的prokinetic代理:纳米粒子和超越
Rameshwar Dass1,2, Meenakshi Bhatia1, Goutam Rath3
1Department of Pharmaceutics, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India.
Current drug delivery
|March 13, 2026
概括
一篇发表的文章在表7中出现了引用编号错误,引用次数高达[228]但只有224条. 这已经被纠正,不会影响科学发现.
科学领域:
- 科学出版 科研出版
- 学术传播学术交流
背景情况:
- 发表文章的第7表中的参考编号中发现了差异.
- 表7中的引用被编号为[228],而参考列表只包含了224条条目.
研究的目的:
- 在发表的科学文章中解决和纠正在参考编号中发现的错误.
主要方法:
- 这种不一致被认为是手稿准备过程中的错误.
- 表7中的参考编号已被修订,以准确匹配参考列表.
主要成果:
- 表7中的编号错误已被纠正.
- 校正确保了文本内引用与参考列表之间的准确对齐.
结论:
- 纠正参考编号不会改变文章的科学内容,数据解释或结论.
- 这种错误确保了公布记录的完整性和准确性.
相关概念视频
Oral Drug Delivery Systems: Introduction
149
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
149
Oral Drug Delivery Systems: Delayed-Release Systems
91
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
91
Modified-Release Drug Delivery Systems: Overview
97
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
97
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.9K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.9K
Oral Drug Delivery Systems: Continuous-Release Systems
135
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
135
Drug Delivery: Overview
1.1K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.1K


